Statement
21 May 2026
79th World Health Assembly (WHA79): Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases
On 21 May 2026, IFPMA published a statement on the follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases, on the margins of the World Health Assembly. IFPMA welcomes WHO’s continued efforts to tackle one of the greatest health challenges of our lifetimes....
Read more
External study
4 Mar 2026
Financing health systems: Leveraging the benefits of investing in prevention against NCDs
Investing in the prevention and treatment of non-communicable diseases (NCDs) can strengthen health systems, protect economic productivity, and improve population wellbeing. Evidence shows that every dollar invested in preventing and managing NCDs generates substantial returns through reduced healthcare costs, improved workforce participation, and healthier, more resilient societies. Yet despite this compelling investment case, progress remains...
Read more
Statement
2 Feb 2026
158th session of the WHO Executive Board (EB158): Priorities for financing noncommunicable diseases to achieve universal health coverage
On 2 February 2026, PATH delivered a joint constituency statement on Agenda itea 6: Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases at the 158th session of the WHO Executive Board. Sustainable and responsible financing—powered by multisectoral collaboration—is key to meet the...
Read more
